Tandem Releases Positive Results Of T:slim X2 Pump Studies
Zacks Investment Research | Jun 10, 2019 07:42AM ET
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) , recently announced positive results from two studies of the t: slim X2 insulin pump with Control-IQ advanced hybrid closed-loop technology. Details from the two studies, which included Protocol 3 (DCLP3) of the National Institutes of Health (NIH)-funded International Diabetes Closed Loop (iDCL) trial and provisional data from the Freelife Kid AP study, were presented recently at the 79th Scientific Sessions of the American Diabetes Association (ADA).
The results of the studies are considered to be a major breakthrough by the company in the field of diabetes management.
Results in Details
The t:slim X2 insulin pump with Control-IQ technology uses Dexcom G6 CGM sensor values to forecast glucose levels and adjust insulin delivery to ensure the prevention of erratic highs and lows.
The NIH-funded DCLP3 study was performed on people with and without prior experience with insulin pump therapy. Those using Control-IQ technology also saw statistically significant improvements in HbA1c and reductions in mean glucose. A case of diabetic ketoacidosis (DKA) was reported in the Control-IQ study arm due to an infusion set failure. Moreover, no severe hypoglycemia was reported in the study.
The Freelife Kid AP study is a multi-center, randomized evaluation of the proficiency of closed-loop insulin therapy in prepubertal children. The study participants using Control-IQ technology showcased a reduction in mean glucose. Moreover, no case of severe hypoglycemia was reported in this case as well.
The results prove that t:slim X2 insulin pump with Control-IQ technology helps to improve glycemic control and is convenient for patients to use.
Market prospects
Per Original post
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.